Sharps Technology Inc. (STSS)
0.03
-0.00 (-7.41%)
At close: Apr 16, 2025, 3:59 PM
0.03
6.11%
After-hours: Apr 16, 2025, 07:59 PM EDT
-7.41% (1D)
| Bid | 0.02 |
| Market Cap | 427.95K |
| Revenue (ttm) | 8.23K |
| Net Income (ttm) | -9.3M |
| EPS (ttm) | -7.4 |
| PE Ratio (ttm) | n/a |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 0.03 |
| Volume | 96,548,063 |
| Avg. Volume (20D) | 91,922,408 |
| Open | 0.04 |
| Previous Close | 0.03 |
| Day's Range | 0.02 - 0.04 |
| 52-Week Range | 0.01 - 18.15 |
| Beta | 2.08 |
About STSS
Sharps Technology Inc., a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. The company was incorporated in 2017 and is based in Melville, New York....
Industry Medical - Instruments & Supplies
Sector Healthcare
IPO Date Apr 14, 2022
Employees 55
Stock Exchange NASDAQ
Ticker Symbol STSS
Website https://sharpstechnology.com
2 months ago
-68.05%
Sharps Technology shares are trading lower after t...
Unlock content with
Pro Subscription
6 months ago
-26.78%
Sharps Technology shares are trading lower after the company announced that it has entered into definitive agreements with institutional investors for a secured bridge loan financing of approximately $3.5 million.
11 months ago · https://www.defenseworld.net
Head-To-Head Analysis: NeuroMetrix (NASDAQ:NURO) & Sharps Technology (NASDAQ:STSS)NeuroMetrix (NASDAQ:NURO – Get Free Report) and Sharps Technology (NASDAQ:STSS – Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast t...